Skip to main
PHR

Phreesia Inc (PHR) Stock Forecast & Price Target

Phreesia Inc (PHR) Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 36%
Buy 64%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Phreesia Inc. demonstrated strong financial performance with total revenue per Accountable Healthcare Services Client (AHSC) increasing by 5.6% year-over-year, driven by client expansions across its comprehensive suite of solutions. The company's patient payment volumes also grew 9.3% year-over-year, reaching $1.181 billion for the third quarter of FY26, reflecting continued growth from both new and existing clients. Additionally, Phreesia raised its FY26 adjusted EBITDA guidance to a range of $99 million to $101 million, indicating significant year-over-year growth of 172% and outperforming consensus estimates, alongside an anticipated increase in total revenue per AHSC for FY26.

Bears say

Phreesia Inc. reported 3Q26 revenue of $120.3 million, which was marginally below the expected $120.4 million, indicating potential challenges in revenue growth amidst a competitive landscape. Additionally, the company ended the quarter with 4,520 provider clients, falling short of consensus expectations and reflecting slower client acquisition, contributing to a negative outlook on its growth trajectory. Concerns also persist regarding the potential impact of another COVID-19 surge on patient visit volumes, which could further hinder Phreesia's topline growth and financial performance.

Phreesia Inc (PHR) has been analyzed by 14 analysts, with a consensus rating of Buy. 36% of analysts recommend a Strong Buy, 64% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Phreesia Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Phreesia Inc (PHR) Forecast

Analysts have given Phreesia Inc (PHR) a Buy based on their latest research and market trends.

According to 14 analysts, Phreesia Inc (PHR) has a Buy consensus rating as of Jan 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $31.29, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $31.29, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Phreesia Inc (PHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.